The inhibition of IRE1α RNase activity with the small-molecule 4μ8c suppresses the drug-induced expression of these ABC transporters and resensitizes 5-FU-resistant colon cancer cells to drug treatment (Gao et al., 2020). The gene discussed is ABCG2; the disease is malignant colon neoplasm.